MEDICAL PSILOCYBIN ACT
New Mexico legalized medical psilocybin for mental health treatment in licensed facilities, creating the first comprehensive state regulatory framework for psychedelic-assisted therapy.
New Mexico legalized medical psilocybin for mental health treatment in licensed facilities, creating the first comprehensive state regulatory framework for psychedelic-assisted therapy.
SB 219 establishes New Mexico's Medical Psilocybin Act, creating a regulated program allowing qualified patients with certain mental health conditions to access psilocybin under clinical supervision. The bill sets up licensing requirements for treatment centers, practitioner qualifications, and patient eligibility criteria while maintaining criminal penalties for unlicensed distribution.
This makes New Mexico one of the earliest states to legalize psilocybin for medical use, potentially offering therapeutic options for treatment-resistant depression, PTSD, and other conditions where traditional medications have failed. It reflects broader medical and scientific reassessment of psychedelic compounds' therapeutic potential, with implications for mental health treatment access and pharmaceutical regulation nationwide.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.